Related Experiment Video
Updated: Jan 31, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Albumin nanoparticles conjugates binding with glycan - A strategic approach for targeted drug delivery
Neha Kumari1, V L Mathe2, P M Dongre3
1Department of Physics, Savitribai Phule Pune University, Pune, India; Department of Biophysics, University of Mumbai, 400098, India.
Abstract:
Understanding the transcytosis phenomenon through albumin binding receptor (glycoproteins) is an important step towards targeted drug delivery research. The transcytosis of bovine serum albumin (BSA) occurs through its uptake by binding to glycoprotein (gp60) present on the endothelial cell membrane. gp60 possess abundant glycans like N-acetylneuraminic acid (sialic acid, NANA), l-fucose (FUC), N-acetyl glucosamine (NAG), d-mannose (MAN) and d-galactose (GAL). Hence, the objective of the present study was to insight the binding between BSA-gold nanoparticles (GNPs) and BSA-silver nanoparticles (SNPs) conjugates with model glycans using several biophysical techniques. The fluorescence spectroscopy analysis established the strong affinity of BSA-NPs conjugates with glycan's as observed with the bimolecular quenching rate, the Stern-Volmer constant (Ksv), binding constant and binding site. The increase in hydrodynamic radii of conjugates exhibited strong association and zeta potential confirmed the significant stability of conjugates. Circular dichroism (CD) study showed that the substantial amount of secondary structure (α-helix) was retained in NPs bound BSA while interacting with glycans. Raman spectroscopy study of BSA-GNP and BSA-SNP with glycans depicted the intrusion in the spectral range of 400-1800 cm-1. The overall results showed that BSA-NPs conjugates can act as a virtuous system for targeted drug delivery in endothelial cells.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Drug Distribution: Tissue Binding
For...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...

